UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 710

Sortiert nach

Metastasis-directed radiotherapy for non-small cell lung cancer failured under TKI: A case report and literature review

Cancer radiothérapie, 2023-12, Vol.27 (8), p.731-735

2023

Volltextzugriff (PDF)

PILE: a candidate prognostic score in cancer patients treated with immunotherapy

Clinical & translational oncology, 2021-08, Vol.23 (8), p.1630-1636

2021

Volltextzugriff (PDF)

Cancer patients and oncology nursing: Perspectives of oncology nurses in Turkey

Nigerian journal of clinical practice, 2017-09, Vol.20 (9), p.1065-1073

2017

Volltextzugriff (PDF)

cTnT can be a useful marker for early detection of anthracycline cardiotoxicity

Annals of oncology, 2005-05, Vol.16 (5), p.798-804

2005

Volltextzugriff (PDF)

The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey

Annals of oncology, 2018-10, Vol.29, p.viii505-viii505

2018

Volltextzugriff (PDF)

1862 Pleomorphic lobular carcinoma of the breast associated with impaired overall survival

European journal of cancer (1990), 2015-09, Vol.51, p.S286-S286

2015

Volltextzugriff (PDF)

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?

Annals of oncology, 2010-04, Vol.21 (4), p.902-903

2010

Volltextzugriff (PDF)

Quality of Life Domains Associated With Readmission

Value in health, 2015-05, Vol.18 (3), p.A211-A212

2015

Volltextzugriff (PDF)

FDG–PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?

Annals of oncology, 2009-06, Vol.20 (6), p.1149-1150

2009

Volltextzugriff (PDF)

A critical analysis of publication rates of national oncology meeting abstracts in Turkey

Journal of oncological science, 2018-04, Vol.4 (1), p.24-28

2018

Volltextzugriff (PDF)

Adjuvant chemotherapy and prognosis in patients with breast cancer

Annals of oncology, 2009-01, Vol.20 (1), p.192-193

2009

Volltextzugriff (PDF)

AB0392 Not Increased Cancer Frequency at Patients with Rheumatoid Arthritis During TNF Inhibitor Treatments: Hur-Bio Real Life Results

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1024

2015

Volltextzugriff (PDF)

FRI0272 Five Factor Score (FFS) and its Relationship with Mortality in Granulomatous Poliangiitis (GPA)

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.523-523

2015

Volltextzugriff (PDF)

THU0226 ASAS Partial Remission Ratio of as and Axial Spondyloarthritis Patients During Anti-TNF Treatments: HUR-BIO Real Life Results

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.278-278

2015

Volltextzugriff (PDF)

THU0230 Anti-TNF Alpha Drugs Retention Rate at Ankylosing Spondylitis and Axial Spondyloarthritis: HUR-BIO Real Life Results

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.279-280

2015

Volltextzugriff (PDF)

Association of Health Care Cost with Quality of Life for Various Types of Cancers

Value in health, 2014-11, Vol.17 (7), p.A631-A631

2014

Volltextzugriff (PDF)

Trastuzumab treatment beyond brain progression in HER2- positive metastatic breast cancer

Annals of oncology, 2009-01, Vol.20 (1), p.192-192

2009

Volltextzugriff (PDF)

HPR12 Treatment Inequities Among Cancer Patients Due to Reimbursement: From the Perspective of 130 Medical Oncologists

Value in health, 2022-12, Vol.25 (12), p.S234-S234

2022

Volltextzugriff (PDF)

Accelerated hepatitis C virus replication with rituximab treatment in a non‐Hodgkin's lymphoma patient

Clinical and laboratory haematology, 2006-06, Vol.28 (3), p.211-214

2006

Volltextzugriff (PDF)

Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors

International journal of laboratory hematology, 2008-06, Vol.30 (3), p.214-219

2008

Volltextzugriff (PDF)

85P The association between diabetes and survival in patients treated with immunotherapy

Annals of oncology, 2021-12, Vol.32, p.S1409

2021

Volltextzugriff (PDF)

Stevens–Johnson Syndrome after Treatment with Capecitabine

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008-03, Vol.20 (2), p.202-203

2008

Volltextzugriff (PDF)

P2.06-10 Disease Progression on PROs in Patients With aNSCLC With PD-L1 ≥50% Receiving Cemiplimab vs Chemotherapy: EMPOWER-Lung 1

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S321

2023

Volltextzugriff (PDF)

1183P Patient-reported outcomes (PROs) of cemiplimab vs chemotherapy in advanced non-small cell lung cancer (aNSCLC): EMPOWER-Lung 1 histology subgroups

Annals of oncology, 2022-09, Vol.33, p.S1089

2022

Volltextzugriff (PDF)

Increasing performance of a hospital-based cancer registry: Hacettepe University hospitals experience

Journal of B.U. ON., 2013-10, Vol.18 (4), p.1088-1096

2013

Volltextzugriff (PDF)

1 – 25 von 710

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(650)
Mit Volltextzugriff
(544)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Metastasis-directed radiotherapy for non-small cell lung cancer failured under TKI: A case report and literature review

PILE: a candidate prognostic score in cancer patients treated with immunotherapy

Cancer patients and oncology nursing: Perspectives of oncology nurses in Turkey

cTnT can be a useful marker for early detection of anthracycline cardiotoxicity

The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey

1862 Pleomorphic lobular carcinoma of the breast associated with impaired overall survival

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?

Quality of Life Domains Associated With Readmission

FDG–PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?

A critical analysis of publication rates of national oncology meeting abstracts in Turkey

Adjuvant chemotherapy and prognosis in patients with breast cancer

AB0392 Not Increased Cancer Frequency at Patients with Rheumatoid Arthritis During TNF Inhibitor Treatments: Hur-Bio Real Life Results

FRI0272 Five Factor Score (FFS) and its Relationship with Mortality in Granulomatous Poliangiitis (GPA)

THU0226 ASAS Partial Remission Ratio of as and Axial Spondyloarthritis Patients During Anti-TNF Treatments: HUR-BIO Real Life Results

THU0230 Anti-TNF Alpha Drugs Retention Rate at Ankylosing Spondylitis and Axial Spondyloarthritis: HUR-BIO Real Life Results

Association of Health Care Cost with Quality of Life for Various Types of Cancers

Trastuzumab treatment beyond brain progression in HER2- positive metastatic breast cancer

HPR12 Treatment Inequities Among Cancer Patients Due to Reimbursement: From the Perspective of 130 Medical Oncologists

Accelerated hepatitis C virus replication with rituximab treatment in a non‐Hodgkin's lymphoma patient

Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors

85P The association between diabetes and survival in patients treated with immunotherapy

Stevens–Johnson Syndrome after Treatment with Capecitabine

P2.06-10 Disease Progression on PROs in Patients With aNSCLC With PD-L1 ≥50% Receiving Cemiplimab vs Chemotherapy: EMPOWER-Lung 1

1183P Patient-reported outcomes (PROs) of cemiplimab vs chemotherapy in advanced non-small cell lung cancer (aNSCLC): EMPOWER-Lung 1 histology subgroups

Increasing performance of a hospital-based cancer registry: Hacettepe University hospitals experience

Suchergebnisse filtern